Get insight from foundation experts on research, treatment and prevention, plus the very latest news and events.
Switch on your HIV smarts.
A small pilot study conducted with HIV-positive men who have sex with men found evidence that a daily dose of the antibiotic doxycycline provides a protective effect against three sexually … Read More
A replacement for Truvada—the widely-used combination HIV antiretroviral medication and the only approved medication for pre-exposure prophylaxis (PrEP)—is now on the horizon. On April 7, 2015, Gilead Sciences submitted an … Read More
With a continually increasing number of people beginning to take the drug Truvada as pre-exposure prophylaxis (PrEP) to prevent HIV, some have raised concerns that this might lead to more … Read More
Join us for daily news and commentary on HIV/AIDS treatment, prevention and policy.
The foundation's ongoing forum series bringing research and evidence to bear on timely policy and programmatic issues.